Increased serum sPD-1 levels have been described previously in established RA [21–23], and sPD-1 enhances pro-inflammatory cytokine expression and aggravates joint pathology in a murine collagen-induced arthritis model [24]. Here, HOXD13 is linked to arthritic joint disease.